Treatment of yellow nail syndrome with octreotide

G. Hillerdal (Stockholm, Sweden)

Source: Annual Congress 2007 - Orphan diseases
Session: Orphan diseases
Session type: Thematic Poster Session
Number: 3384

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Hillerdal (Stockholm, Sweden). Treatment of yellow nail syndrome with octreotide. Eur Respir J 2007; 30: Suppl. 51, 3384

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Yellow nail syndrome, a case presentaion
Source: Eur Respir J 2006; 28: Suppl. 50, 579s
Year: 2006

Familial yellow nail syndrome: a case report
Source: Eur Respir J 2002; 20: Suppl. 38, 444s
Year: 2002

Effectiveness of long-term treatment with erythromycin in patients with Asthma-COPD overlap syndrome
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019


Severe form of croup syndrome - treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 82s
Year: 2002

Yellow nail syndrome: does protein leakage play a role?
Source: Eur Respir J 2001; 17: 149-152
Year: 2001



Yellow nail syndrome: analysis of 41 consecutive patients
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Successive treatment of Churg-Strauss syndrome with cyclesonide after oral steroids discontinuation due to side effects
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Assessment and treatment of congenital central hypoventilation syndrome in children
Source: Sleep and Breathing Conference 2021
Year: 2021


A new syndrome or bilateral Poland’s syndrome
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013


Treatment of sarcoidosis – pentoxifylline
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019

New therapy for pulmonary-renal Goodpasture‘s syndrome
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b
Source: Eur Respir J 2002; 20: Suppl. 38, 157s
Year: 2002

Succesful treatment of an adolescent with lymphedema-distichiasis syndrome
Source: Annual Congress 2007 - Orphan diseases
Year: 2007


Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006

Hand-Schuller-Christian syndrome: diagnosis and treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Treatment strategies in obesity hypoventilation and overlap syndrome
Source: Annual Congress 2010 - Challenges in sleep medicine: ventilatory failure during sleep
Year: 2010


Effect of 2-Year therapy with Roflumilast in severe systemic inflammation in COPD with metabolic syndrome
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019


Severe persistent asthma in children with Ehlers-Danlos’ syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

The effect of Octreotide in patients with refractory Chronic Cough
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020